Skip to main content

Table 2 Effect of carbimazole drug and xylo-oligosaccharide co-administration on serum liver and kidney functions in female rats

From: Role of xylo-oligosaccharides in relieving complications accompanied to carbimazole drug administrated with 1% saline in female Wistar rats

Groups parameters

Carbimazole (positive)

Carbimazole and xylo-oligosaccarides co-administration (treated)

1% saline control

Normal Control

ALT (U/ ml)

11.62 ± 0.59c

12.89 ± 0.69

12.65 ± 0.94

13.98 ± 1.41b

AST (U/ml)

45.00 ± 5a,c,d

54.5 ± 1.5a,b

64.5 ± 0.2b,c,d

55.33 ± 5a,b

Total protein (g/dl)

10.3 ± 0.015a,c,d

8.32 ± 0.065a,b,c

7.42 ± 0.25b,c,d

7.95 ± 0.057a,b,d

Urea (mg/dl)

16.75 ± 5.06c,d

69.06 ± 12.42a,b,c

25.66 ± 11.64d

40.57 ± 2.68b,d

Creatinine (mg/dl)

1.185 ± 0.002a,c,d

0.77 ± 0.148b

0.925 ± 0.003b

0.931 ± 0.031b

Total calcium (mg/dl)

15.15 ± 0.25c

14.50 ± 0.30

13.55 ± 0.05

12.80 ± 2.00b

  1. Pa significant to 1% saline gp
  2. Pb significant to positive gp
  3. Pc significant to normal control gp
  4. Pd significant to treated group